Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use
Open Access
- 2 September 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (11) , 1955-1968
Abstract
It has long been known that pregnancy and childbirth have a profound effect on the disease activity of rheumatic diseases. For clinicians, the management of patients with RA wishing to become pregnant involves the challenge of keeping disease activity under control and adequately adapting drug therapy during pregnancy and post-partum. This article aims to summarize the current evidence on the evolution of RA disease activity during and after pregnancy and the use of anti-rheumatic drugs around this period. Of recent interest is the potential use of anti-TNF compounds in the preconception period and during pregnancy. Accumulating experience with anti-TNF therapy in other immune-mediated inflammatory diseases, such as Crohn’s disease, provides useful insights for the use of TNF blockade in pregnant women with RA, or RA patients wishing to become pregnant.Keywords
This publication has 120 references indexed in Scilit:
- The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis RegisterAnnals of the Rheumatic Diseases, 2010
- Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to toleranceProceedings of the National Academy of Sciences, 2010
- Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feedingInflammatory Bowel Diseases, 2010
- Birth outcomes in women who have taken leflunomide during pregnancyArthritis & Rheumatism, 2010
- Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort studyArthritis Research & Therapy, 2009
- Certolizumab use in pregnancyGut, 2009
- Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans?The Journal of Rheumatology, 2009
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration DatabaseThe Journal of Rheumatology, 2009
- A meta-analysis on the influence of inflammatory bowel disease on pregnancyGut, 2006
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004